Evoflo

Main information

  • Trade name:
  • Evoflo 25mcg + 50mcg Suspension, inhalation
  • Dosage:
  • 25mcg + 50mcg
  • Pharmaceutical form:
  • Suspension, inhalation
  • Units in package:
  • Canister with dose counter x 120 actuations
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug
  • Manufactured by:
  • Glaxo Wellcome S.A.

Documents

Localization

  • Available in:
  • Evoflo 25mcg + 50mcg Suspension, inhalation
    Philippines
  • Language:
  • English

Status

  • Source:
  • FDA - Food And Drug Administration - Philippines
  • Authorization number:
  • DRP-5118-01
  • Authorization date:
  • 15-01-2019
  • Last update:
  • 10-07-2018